EXACTECH INC 4
4 · EXACTECH INC · Filed Feb 27, 2017
Insider Transaction Report
Form 4
EXACTECH INCEXAC
Thompson Bruce E
Sr VP, Biologics/Spine
Transactions
- Exercise/Conversion
Incentive/Non-Qualified Stock Option (right to buy)
2016-02-23$18.95/sh−3,306$62,649→ 2,594 totalExercise: $18.95From: 2014-02-02Exp: 2017-02-28→ Common Stock (5,900 underlying) - Exercise/Conversion
Common Stock
2017-02-24$18.95/sh+1,600$30,320→ 26,231 total - Sale
Common Stock
2017-02-24$24.82/sh−1,600$39,712→ 24,631 total - Exercise/Conversion
Incentive/Non-Qualified Stock Option (right to buy)
2017-02-24$18.95/sh−1,600$30,320→ 994 totalExercise: $18.95From: 2014-02-02Exp: 2017-02-28→ Common Stock (5,900 underlying) - Exercise/Conversion
Common Stock
2017-02-23$18.95/sh+3,306$62,649→ 27,937 total - Sale
Common Stock
2017-02-23$24.75/sh−3,306$81,824→ 24,631 total
Holdings
- 12,000
Non-Qualified Stock Option (right to buy)
Exercise: $20.90From: 2019-05-09Exp: 2021-05-09→ Common Stock (12,000 underlying) - 23,800
Incentive/Non-Qualified Stock Option (right to buy)
Exercise: $16.33From: 2017-02-22Exp: 2019-02-22→ Common Stock (23,800 underlying) - 20,000
Incentive/Non-Qualified Stock Option (right to buy)
Exercise: $18.55From: 2018-02-25Exp: 2020-02-25→ Common Stock (20,000 underlying) - 9,000
Non-Qualified Stock Option (right to buy)
Exercise: $23.28From: 2020-04-29Exp: 2022-04-29→ Common Stock (9,000 underlying)
Footnotes (3)
- [F1]Such options are currently exercisable as regards 16,000 of the covered shares. The remaining options are exercisable, as regards 4,000 of the covered shares, on the fifth anniversary of the date of grant.
- [F2]Such options are currently exercisable as regards 4,800 of the covered shares. The remaining options are exercisable, as regards 2,400 of the covered shares, on the third anniversary of the date of grant, as regards 2,400 of the covered shares on the fourth anniversary of the date of grant, and as regards 2,400 of the covered shares, on the fifth anniversary of the date of grant.
- [F3]Such options are currently exercisable as regards 1,800 of the covered shares. The remaining options are exercisable, as regards 1,800 of the covered shares, on the second anniversary of the date of grant, as regards 1,800 of the covered shares, on the third anniversary of the date of grant, as regards 1,800 of the covered shares on the fourth anniversary of the date of grant, and as regards 1,800 of the covered shares, on the fifth anniversary of the date of grant.